Literature DB >> 24305042

Human T-lymphotropic virus/HIV co-infection: a clinical review.

Divya Dhasmana1, Graham P Taylor.   

Abstract

PURPOSE OF REVIEW: Human T-lymphotropic virus (HTLV)/HIV co-infections are often undiagnosed, with important clinical implications. The literature is relatively sparse with key observations derived in the pre-highly-active antiretroviral therapy era. RECENT
FINDINGS: The epidemiology of co-infection, the impact of each virus on the other, with particular reference to clinical manifestations and the impact of antiretroviral therapy on HTLVs are described.
SUMMARY: Important clinical effects of HTLV/HIV co-infection include the higher rates of myelopathy and other neurological disorders and the poor predicative value of CD4+ cell counts as a surrogate for immune suppression. Current antiretroviral therapies in isolation have no proven effect on HTLV-1/2 proviral load.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24305042     DOI: 10.1097/QCO.0000000000000027

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  8 in total

1.  Acute myelitis as presenting symptom of HIV-HTLV-1 co-infection.

Authors:  A Cucca; L Stragapede; L Antonutti; M Catalan; I Caracciolo; Romina Valentinotti; A Granato; P D'Agaro; P Manganotti
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

2.  Distribution of Human Immunodeficiency Virus and Human T-Leukemia Virus Co-infection in Bahia, Brazil.

Authors:  Felicidade Mota Pereira; Fred Luciano Neves Santos; Ângelo Antônio Oliveira Silva; Nathan Menezes Nascimento; Maria da Conceição Chagas Almeida; Roberto Perez Carreiro; Bernardo Galvão-Castro; Maria Fernanda Rios Grassi
Journal:  Front Med (Lausanne)       Date:  2022-01-10

Review 3.  HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review.

Authors:  Daniel Bradshaw; Graham Philip Taylor
Journal:  Front Med (Lausanne)       Date:  2022-04-29

4.  Human T-Lymphotropic virus type 1 and human immunodeficiency virus co-infection in rural Gabon.

Authors:  Augustin Mouinga-Ondémé; Larson Boundenga; Ingrid Précilya Koumba Koumba; Antony Idam Mamimandjiami; Abdoulaye Diané; Jéordy Dimitri Engone-Ondo; Delia Doreen Djuicy; Jeanne Sica; Landry Erik Mombo; Antoine Gessain; Avelin Aghokeng Fobang
Journal:  PLoS One       Date:  2022-07-22       Impact factor: 3.752

5.  HTLV-1 and HIV-1 co-infection: A case report and review of the literature.

Authors:  Carmen Isache; Michael Sands; Nilmarie Guzman; Danisha Figueroa
Journal:  IDCases       Date:  2016-04-07

6.  SEROPREVALENCE OF HTLV IN A POPULATION OF HIV1-INFECTED PATIENTS IN MIDWESTERN BRAZIL.

Authors:  Aline Garcia Kozlowski; Márcia Alves Dias de Matos; Megmar Aparecida Dos Santos Carneiro; Carmen Luci Rodrigues Lopes; Sheila Araújo Teles; Carolina Paulo Vicente; Regina Maria Bringel Martins
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-11-03       Impact factor: 1.846

Review 7.  Neurological Aspects of HIV-1/HTLV-1 and HIV-1/HTLV-2 Coinfection.

Authors:  Abelardo Q-C Araujo
Journal:  Pathogens       Date:  2020-03-28

8.  Prevalence and Molecular Epidemiology of Human T-Lymphotropic Virus (HTLV) Infection in People Living With HIV/AIDS in the Pará State, Amazon Region of Brazil.

Authors:  Samira Peixoto Alencar; Marlinda de Carvalho Souza; Ricardo Roberto de Souza Fonseca; Cláudia Ribeiro Menezes; Vânia Nakauth Azevedo; Andre Luis Ribeiro Ribeiro; Sandra Souza Lima; Rogério Valois Laurentino; Maria Dos Anjos de Abreu Pina Barbosa; Felipe Bonfim Freitas; Aldemir Branco Oliveira-Filho; Luiz Fernando Almeida Machado
Journal:  Front Microbiol       Date:  2020-10-22       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.